IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Reviva Pharmaceuticals Holdi (RVPH)

CUSIP: 76152G209 | NYSE | 39 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AMillennium Management LLC1,072,6908.2%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/ABarclays PLC200.0%Newly reported

Institutional Holders — Q3 2026

Miller Global Investments, LLC1
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Miller Global Investments, LLC
1$00.0%ValueMediumDallas, TX2026-10-02
Jun 30, 2026
Not yet in a 13F
13G/AUBS Group AG00.0%No shares heldJun 30, 20265,269 sh (Mar 31, 2026)
13D/AParag Saxena363,2802.8%Newly reportedMar 20, 2026No 13F filer matched
13G/AMillennium Management LLC1,072,690
8.2% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched
13G/ABarclays PLC20
0.0% of class · Jun 30, 2026Newly reported
Not yet in a 13F
13G/AUBS Group AG0
0.0% of class · Jun 30, 2026No shares held
5,269 sh (Mar 31, 2026)
13D/AParag Saxena363,280
2.8% of class · Mar 20, 2026Newly reported
No 13F filer matched